Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Payer focus in the personalised world of oncology and orphan diseases

Payer focus in the personalised world of oncology and orphan diseases more effective (eg Herceptin in HER2+ breast cancer, Iressa and Tarceva in EGFR mutation+ non-small cell lung cancer and Glivec in Philadelphia chromosome+ CML).

FDA expands use of Roche/ Astellas’ Tarceva in lung cancer patients

FDA expands use of Roche/ Astellas’ Tarceva in lung cancer patients New indication approved alongside companion diagnostic to detect gene mutation. More patients with lung cancer in the US will have access to Roche/ Astellas' oncology medicine Tarceva after the FDA approved ... The US regulator yesterday backed Tarceva

Research units to close as Astellas restructures

Research units to close as Astellas restructures lung cancer therapy Tarceva (erlotinib) - which was bought by Astellas in 2010.

Novartis’ Jakavi turned down by NICE for blood cancer

Novartis’ Jakavi turned down by NICE for blood cancer UK cost-effectiveness watchdog concerned about 'uncertainties' in data in draft guidance

FDA fast tracks two new lung cancer drugs

FDA fast tracks two new lung cancer drugs Meanwhile, Roche and Astellas have been given a fast-track review for their EGFR inhibitor Tarceva (erlotinib) in first-line NSCLC, an indication for which it was approved in Europe in ... Tarceva's application comes on the back of the EURTAC trial,

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics